日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

作者更正:针对未感染过SARS-CoV-2病毒的人群中,针对Omicron BA.2变异株的真实世界COVID-19疫苗有效性

Lau, Jonathan J; Cheng, Samuel M S; Leung, Kathy; Lee, Cheuk Kwong; Hachim, Asmaa; Tsang, Leo C H; Yam, Kenny W H; Chaothai, Sara; Kwan, Kelvin K H; Chai, Zacary Y H; Lo, Tiffany H K; Mori, Masashi; Wu, Chao; Valkenburg, Sophie A; Amarasinghe, Gaya K; Lau, Eric H Y; Hui, David S C; Leung, Gabriel M; Peiris, Malik; Wu, Joseph T

Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents

青少年皮内注射与肌肉注射相比,对CoronaVac疫苗产生更优的抗体和膜蛋白特异性T细胞反应

Rosa Duque, Jaime S; Cheng, Samuel M S; Cohen, Carolyn A; Leung, Daniel; Wang, Xiwei; Mu, Xiaofeng; Chung, Yuet; Lau, Tsun Ming; Wang, Manni; Zhang, Wenyue; Zhang, Yanmei; Wong, Howard H W; Tsang, Leo C H; Chaothai, Sara; Kwan, Tsz Chun; Li, John K C; Chan, Karl C K; Luk, Leo L H; Ho, Jenson C H; Li, Wing Yan; Lee, Amos M T; Lam, Jennifer H Y; Chan, Sau Man; Wong, Wilfred H S; Tam, Issan Y S; Mori, Masashi; Valkenburg, Sophie A; Peiris, Malik; Tu, Wenwei; Lau, Yu Lung

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

在未感染过SARS-CoV-2的人群中,针对Omicron BA.2变异株的COVID-19疫苗在真实世界中的有效性

Lau, Jonathan J; Cheng, Samuel M S; Leung, Kathy; Lee, Cheuk Kwong; Hachim, Asmaa; Tsang, Leo C H; Yam, Kenny W H; Chaothai, Sara; Kwan, Kelvin K H; Chai, Zacary Y H; Lo, Tiffany H K; Mori, Masashi; Wu, Chao; Valkenburg, Sophie A; Amarasinghe, Gaya K; Lau, Eric H Y; Hui, David S C; Leung, Gabriel M; Peiris, Malik; Wu, Joseph T

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

比较使用 CoronaVac 和 BNT162b2 (Cobovax) 进行同源和异源加强免疫的抗体和细胞介导免疫反应、反应原性和疗效:一项开放标签、随机试验

Leung, Nancy H L; Cheng, Samuel M S; Cohen, Carolyn A; Martín-Sánchez, Mario; Au, Niki Y M; Luk, Leo L H; Tsang, Leo C H; Kwan, Kelvin K H; Chaothai, Sara; Fung, Lison W C; Cheung, Alan W L; Chan, Karl C K; Li, John K C; Ng, Yvonne Y; Kaewpreedee, Prathanporn; Jia, Janice Z; Ip, Dennis K M; Poon, Leo L M; Leung, Gabriel M; Peiris, J S Malik; Valkenburg, Sophie A; Cowling, Benjamin J

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine

在接种过两剂灭活疫苗的成年人中,第三剂BNT162b2对祖先型严重急性呼吸综合征冠状病毒2和Omicron变异株的免疫原性

Leung, Nancy H L; Cheng, Samuel M S; Martín-Sánchez, Mario; Au, Niki Y M; Ng, Yvonne Y; Luk, Leo L H; Chan, Karl C K; Li, John K C; Leung, Yonna W Y; Tsang, Leo C H; Chaothai, Sara; Kwan, Kelvin K H; Ip, Dennis K M; Poon, Leo L M; Leung, Gabriel M; Peiris, J S Malik; Cowling, Benjamin J

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.

健康青少年接种第三剂灭活 COVID-19 疫苗后对野生型和 Omicron SARS-CoV-2 的免疫原性

Leung Daniel, Cohen Carolyn A, Mu Xiaofeng, Rosa Duque Jaime S, Cheng Samuel M S, Wang Xiwei, Wang Manni, Zhang Wenyue, Zhang Yanmei, Tam Issan Y S, Lam Jennifer H Y, Chan Sau Man, Chaothai Sara, Kwan Kelvin K H, Chan Karl C K, Li John K C, Luk Leo L H, Tsang Leo C H, Chu Nym Coco, Wong Wilfred H S, Mori Masashi, Leung Wing Hang, Valkenburg Sophie, Peiris Malik, Tu Wenwei, Lau Yu Lung

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents.

青少年接种第三剂 BNT162b2 后,针对野生型和 Omicron SARS-CoV-2 的抗体和 T 细胞反应

Mu Xiaofeng, Cohen Carolyn A, Leung Daniel, Rosa Duque Jaime S, Cheng Samuel M S, Chung Yuet, Wong Howard H W, Lee Amos M T, Li Wing Yan, Tam Issan Y S, Lam Jennifer H Y, Lee Derek H L, Chan Sau Man, Tsang Leo C H, Chan Karl C K, Li John K C, Luk Leo L H, Chaothai Sara, Kwan Kelvin K H, Chu Nym Coco, Mori Masashi, Jeevan Trushar, Kandeil Ahmed, Webby Richard J, Tu Wenwei, Valkenburg Sophie A, Peiris Malik, Lau Yu Lung

Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

作者更正:SARS-CoV-2疫苗BNT162b2和CoronaVac在健康青少年中的免疫原性和反应原性

Rosa Duque, Jaime S; Wang, Xiwei; Leung, Daniel; Cheng, Samuel M S; Cohen, Carolyn A; Mu, Xiaofeng; Hachim, Asmaa; Zhang, Yanmei; Chan, Sau Man; Chaothai, Sara; Kwan, Kelvin K H; Chan, Karl C K; Li, John K C; Luk, Leo L H; Tsang, Leo C H; Wong, Wilfred H S; Cheang, Cheuk Hei; Hung, Timothy K; Lam, Jennifer H Y; Chua, Gilbert T; Tso, Winnie W Y; Ip, Patrick; Mori, Masashi; Kavian, Niloufar; Leung, Wing Hang; Valkenburg, Sophie; Peiris, Malik; Tu, Wenwei; Lau, Yu Lung

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

SARS-CoV-2疫苗BNT162b2和CoronaVac在健康青少年中的免疫原性和反应原性

Jaime S Rosa Duque # ,Xiwei Wang # ,Daniel Leung # ,Samuel M S Cheng # ,Carolyn A Cohen # ,Xiaofeng Mu ,Asmaa Hachim ,Yanmei Zhang ,Sau Man Chan ,Sara Chaothai ,Kelvin K H Kwan ,Karl C K Chan ,John K C Li ,Leo L H Luk ,Leo C H Tsang ,Wilfred H S Wong ,Cheuk Hei Cheang ,Timothy K Hung ,Jennifer H Y Lam ,Gilbert T Chua ,Winnie W Y Tso ,Patrick Ip ,Masashi Mori ,Niloufar Kavian ,Wing Hang Leung ,Sophie Valkenburg ,Malik Peiris ,Wenwei Tu ,Yu Lung Lau

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity

BNT162b2 和 CoronaVac 疫苗在患有先天性免疫缺陷的儿童和成人中的安全性和免疫原性(3 剂)。

Leung, Daniel; Mu, Xiaofeng; Duque, Jaime S Rosa; Cheng, Samuel M S; Wang, Manni; Zhang, Wenyue; Zhang, Yanmei; Tam, Issan Y S; Lee, Toby S S; Lam, Jennifer H Y; Chan, Sau Man; Cheang, Cheuk Hei; Chung, Yuet; Wong, Howard H W; Lee, Amos M T; Li, Wing Yan; Chaothai, Sara; Tsang, Leo C H; Chua, Gilbert T; Cheong, Kai-Ning; Au, Elaine Y L; Kwok, Janette S Y; Chan, Koon Wing; Chong, Patrick C Y; Lee, Pamela P W; Ho, Marco H K; Lee, Tsz Leung; Tu, Wenwei; Peiris, Malik; Lau, Yu Lung